Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04432493 · ClinicalTrials.gov registry record · NA
Using Combined EEG and Non-invasive Brain Stimulation to Examine and Improve Reward Functioning in Opioid Use Disorder
A NA study, sponsored by Rutgers University.
- Completed
- Registry status
- NA
- Development phase
- 81
- Enrollment target
NCT04432493 is a NA study that has completed, run by Rutgers University. The registered enrollment target is 81 participants.
The verdict
NCT04432493, a NA study, has completed, sponsored by Rutgers University.
- COMPLETED
- Registry status
- NA
- Development phase
- 81 participants
- Enrollment target
Study Summary
The primary aims of this study are to identify impaired cognitive control in opioid use disorder (OUD) and subsequently to examine the effects of transcranial magnetic stimulation (TMS) on reward processing, as measured by the reward positivity (an electrophysiological signal) in people with OUD. To this end, the investigators will adopt a randomized sham-controlled trial to evaluate the efficacy of Ri-TMS on cognitive control in OUD. The investigators hypothesize that Ri-TMS will be successful in modulating the reward positivity in opioid users in the active TMS condition.
Interventions
- DEVICE Sham repetitive transcranial magnetic stimulation (rTMS)
- DEVICE Active repetitive transcranial magnetic stimulation (rTMS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2020-02-20 |
| Est. Completion | 2022-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04432493
The ClinicalTrials.gov registry entry for NCT04432493 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers University, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham repetitive transcranial magnetic stimulation (rTMS) is the first listed.
NCT04432493 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04432493 about?
NCT04432493 is a clinical study titled "Using Combined EEG and Non-invasive Brain Stimulation to Examine and Improve Reward Functioning in Opioid Use Disorder". The primary aims of this study are to identify impaired cognitive control in opioid use disorder (OUD) and subsequently to examine the effects of transcranial magnetic stimulation (TMS) on reward processing, as measured by the reward positivity (an electrophysiological signal) in people with OUD. To...
What is the current status of trial NCT04432493?
This trial is currently completed. It is a NA study. The enrollment target is 81 participants. The study started on 2020-02-20. Estimated completion is 2022-08-31.
What interventions are being tested in trial NCT04432493?
The interventions under investigation include: Sham repetitive transcranial magnetic stimulation (rTMS) (DEVICE), Active repetitive transcranial magnetic stimulation (rTMS) (DEVICE).
Who is sponsoring clinical trial NCT04432493?
This trial is sponsored by Rutgers University, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.